U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033455) titled 'A Trial of HRS-1893 in Healthy Volunteers' on May 20.
Brief Summary: The purpose of this study is to assess the safety and PK characteristics of a single oral dose of HRS-1893 in healthy voluunters.
Study Start Date: June 24
Study Type: INTERVENTIONAL
Condition:
Hypertrophic Cardiomyopathy
Intervention:
DRUG: HRS-1893
Single dose of HRS-1893 orally administered
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Atridia Pty Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....